Vir Biotechnology, Inc.

US$12.21As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VIRHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (2.03%)
Div yield —
ROE (21.84%)
Biotechnology
Beta (5Y) 1.74
PE TTM —
TSR TTM 104.87%
Mkt cap US$2.091B
ROIC (39.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$14
10.65%
(12.53%)
Hold 12|8|3|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.24
0.25
0.26
0.29
35.86%
28.75%
24.12%
19.84%
Revenue$M
133.2
137.4
142.9
143.9
2.45%
7.41%
5.83%
4.93%
Peers (US$2.091B)
Cap (US$)
PE
2.103B
—
2.071B
5.627x
Capital
TTM
5Y
10Y
Leveragex
0.841
(0.234)
(0.220)
EBIT/Intx
0.493
0.394
0.345
Own earn%
(123.25)
(113.92)
(104.04)
Sh yield%
25.97
43.72
47.82
Owners
Insiders/Inst%
14.75
35.70
Short interest%
3.35
SBC / revenue%
0.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
24–30
$1 testx
—
Incr. ROIC%
12